fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
- RxCUI
- 1731077
- RxNorm name
- fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
- Display name
- fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
- Full name
- fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Camber Pharmaceuticals, Inc. | 7dbdf8f5-6936-4143-b52d-96774b799a7d | 2026-08-11 | Warnings, Adverse reactions | 1731077 |
| NAVITRUX | FOSAPREPITANT | AVYXA Pharma, LLC | a41b7c3a-1376-43a7-b5b9-6ba2eba1e169 | 2026-07-29 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT | Northstar Rx LLC | bf207918-100d-4917-88b0-3433c0e72249 | 2026-07-09 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Baxter Healthcare Corporation | 3ed3e0a9-a0a8-4555-9f73-2043e79e3398 | 2026-05-29 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT | Bryant Ranch Prepack | 679c195a-cf59-4ca5-aa05-fa35d08ddb5c | 2026-05-06 | Warnings, Adverse reactions | 1731077 |
| fosaprepitant | FOSAPREPITANT | Mylan Institutional LLC | 9b6d5ea3-2f7a-4501-9a4a-6fa1a7c2d50a | 2026-04-10 | Warnings, Adverse reactions | 1731077 |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Eugia US LLC | 19919480-960b-4741-9611-c133d68512f5 | 2026-04-01 | Warnings, Adverse reactions | 1731077 |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1a7d2f44-b578-4d99-a4ff-f267626064d0 | 2026-03-19 | Warnings, Adverse reactions | 1731077 |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1cc7d482-5d45-4621-9ffc-cd3f7c54614d | 2026-03-19 | Warnings, Adverse reactions | 1731077 |
| EMEND | FOSAPREPITANT DIMEGLUMINE | Merck Sharp & Dohme LLC | 8d66803a-6811-4c29-9c57-e16acfa87f21 | 2026-02-20 | Warnings, Adverse reactions | 1731077 |
| FOSAPREPITANT | FOSAPREPITANT DIMEGLUMINE | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 7375ab3f-a6fc-4601-9415-07b4f681cdef | 2025-12-24 | Warnings, Adverse reactions | 1731077 |
| fosaprepitant | FOSAPREPITANT | BE Pharmaceuticals Inc. | 21b08b87-70e3-4233-9531-dd6d84eab5d0 | 2025-10-09 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT | BluePoint Laboratories | ad89825f-aa31-469f-9685-159a4524dfdc | 2025-10-09 | Warnings, Adverse reactions | 1731077 |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Qilu Pharmaceutical Co., Ltd. | 5bb41bcb-c775-4447-9bd0-d4c55ad110ea | 2025-08-07 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Avenacy, LLC | 3f942e4c-e26a-4155-9e14-344b2970b189 | 2025-07-09 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | BluePoint Laboratories | 2d30d839-bb88-46ce-a9ed-66fe32a12a7a | 2025-07-07 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT | Dr. Reddy's Laboratories Inc., | 557a48d5-0e1f-f3d5-d3bc-db422d19c399 | 2025-05-22 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT | Dr. Reddy's Laboratories Inc., | f34c931c-78b9-90c1-3fa5-bb34a227f2ad | 2024-12-19 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT | Fresenius Kabi USA, LLC | ffee61d1-c1c6-4224-871c-ab7ff6cd01e5 | 2024-06-19 | Warnings, Adverse reactions | 1731077 |
| Fosaprepitant | FOSAPREPITANT | BluePoint Laboratories | 46edae30-d50c-4112-9941-954b13ed5eda | 2024-01-18 | Warnings, Adverse reactions | 1731077 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 679c195a-cf59-4ca5-aa05-fa35d08ddb5c | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 100 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20260506 |
| 44f634f4-b794-4d55-8ab7-037fdef8ff0f | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 30 | These highlights do not include all the information needed to use EMEND FOR INJECTION safely and effectively. See full prescribing information for EMEND FOR INJECTION. EMEND (fosaprepitant) for injection, for intravenous use Initial U.S. Approval: 2008 | 20180326 |
| 8d66803a-6811-4c29-9c57-e16acfa87f21 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 20 | These highlights do not include all the information needed to use EMEND FOR INJECTION safely and effectively. See full prescribing information for EMEND FOR INJECTION. EMEND ® (fosaprepitant) for injection, for intravenous use Initial U.S. Approval: 2008 | 20260220 |
| 9dbd4c29-d894-4839-9b22-a2f65c8c8ad1 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 12 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20220630 |
| 21b08b87-70e3-4233-9531-dd6d84eab5d0 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 9 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20251009 |
| 557a48d5-0e1f-f3d5-d3bc-db422d19c399 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 9 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION . FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20250522 |
| 19919480-960b-4741-9611-c133d68512f5 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 7 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20260401 |
| 5bb41bcb-c775-4447-9bd0-d4c55ad110ea | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 7 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20250807 |
| ffee61d1-c1c6-4224-871c-ab7ff6cd01e5 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 7 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20240619 |
| 1a7d2f44-b578-4d99-a4ff-f267626064d0 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20260319 |
| 7375ab3f-a6fc-4601-9415-07b4f681cdef | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. Fosaprepitant for injection, for intravenous use Initial U.S. Approval: 2008 | 20251224 |
| 2d30d839-bb88-46ce-a9ed-66fe32a12a7a | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20250707 |
| 7dbdf8f5-6936-4143-b52d-96774b799a7d | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20260414 |
| 9b6d5ea3-2f7a-4501-9a4a-6fa1a7c2d50a | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION . FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20260410 |
| df341f63-0fef-4411-a89b-6df6b9e792be | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval. 2008 | 20230725 |
| 1cc7d482-5d45-4621-9ffc-cd3f7c54614d | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 3 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20260319 |
| f34c931c-78b9-90c1-3fa5-bb34a227f2ad | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 3 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20241219 |
| 3f942e4c-e26a-4155-9e14-344b2970b189 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20250709 |
| 46edae30-d50c-4112-9941-954b13ed5eda | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20240118 |
| 0e4ff71c-c0d1-4644-ab80-fd903ff86181 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. Fosaprepitant for injection, for intravenous use Initial U.S. Approval: 2008 | 20231230 |
| 1e6b36b2-3c8b-4ac4-827e-d6f00d999032 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20220930 |
| ad89825f-aa31-469f-9685-159a4524dfdc | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20251009 |
| bf207918-100d-4917-88b0-3433c0e72249 | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20241113 |
| a7343abe-b2b0-4e5a-907b-532a8e16dfcb | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20210101 |
| d624667d-ee3b-3501-53fe-da453352042d | fosaprepitant 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [SCD] · fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION. FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008 | 20200320 |